Association of cross‐classified FASN/PTEN with lethal prostate cancer among men diagnosed with prostate cancer between 1983 and 2004 in the Health Professionals Follow‐Up Study and the Physicians' Health Study. This evidence concerns the gene PTEN and prostate cancer.